Unjustified Stock Market Investors Gloom and Doom
Stock-Markets / Stock Market 2023 Oct 19, 2023 - 10:28 PM GMTBy: Stephen_McBride
I’m sensing a lot of unjustified doom and gloom from  investors.
  Legendary investor Jeremy Grantham recently told  Bloomberg, “No one should invest in the US.”
  I have great respect for the guy, but c’mon… he’s been  predicting Armageddon for a decade straight.
  And look at all these exciting breakthroughs going on…
1. AI will win the Nobel Prize.
The first week of October was Nobel Prize week. And of  course, all the winners were super-smart humans.
  I’m predicting humanity’s winning streak will soon  end.
  It’s only a matter of time before an artificial  intelligence (AI) tool like ChatGPT makes a major medical breakthrough and wins  the Nobel Prize for medicine. Give it three years, max.
  Know what’s amazing? A mechanic can plug a cable into  my car and instantly diagnose a problem. Yet a doctor will often put a human  through a gauntlet of medical tests… and still not have the foggiest idea  what’s wrong.
  AI will help solve our medical riddles. It’s already  made Nobel Prize-worthy breakthroughs.
  In fact, AI recently gave a paralyzed woman named Ann  her voice back.
  AI “learned” her voice by listening to a single  recording of her speaking at her wedding. Researchers built a system that  synthesizes speech from Ann’s brain signals.
  And she doesn’t sound like Stephen Hawking’s robot  voice. Her voice sounds the same as it did before the injury!
  Read that sentence again and tell me humans (plus AI)  don’t rock!
  And there’s plenty more where that came from.
  Facebook founder “Zuck” just announced he’s footing  the bill for a biotech supercomputer “to cure, prevent, or manage all  diseases.” A bad time to be a disease; a great time to be alive.
  As usual, Nvidia (NVDA) is a  clear-cut winner here. There will be tens of millions of “AIs”... and Nvidia’s  chips will power the lot.
  Set your clocks: AI will win a Nobel Prize within three years.
2. This represents everything that’s right with America.
Forget the pyramids or the Colosseum.
  The Las Vegas Sphere is the first wonder of our  (digital) world.
  Standing 350 feet tall and 500 feet wide, the world’s  largest sphere is made up of 1.2 million hockey puck-sized LED lights. It’s  basically a giant, ball-shaped screen.
  The other night, it transformed into a Halloween  pumpkin:
  And oh yeah, there’s an 18,000-seater stadium inside the  Sphere. Rock band U2 are rocking inside in the photo below.
  I have no time for Bono, but wow… where can I buy  tickets? Here’s the inside. Blew. My. Mind.
  Source: CNN 
  This giant orb—plonked in the middle of the Nevada  desert—symbolizes why our future will be better than you can possibly imagine.
  I’m sure you’ve heard people complain America can’t  build things anymore.
  The Empire State Building was built in 400 days. Yet  it’s been 15 years… and the high-speed rail line that’s supposed to connect San  Francisco to LA can’t even get started.
  Las Vegas’s Sphere is 10X more impressive than  anything big tech built in the last decade.
  It represents everything that’s “right” with America.  A big, bold, ambitious project. It’s $2.3 billion well spent.
  It’s a new era for America, friends. Elon Musk is  building rockets to Mars. Florida has high-speed railways. New nuclear power plants? Check.
  Next come the flying cars
  This new era will throw up lots of exciting  opportunities.
  Did you know you can own a piece of the Sphere?
  Sphere Entertainment (SPHR) isn’t good enough to make it into the Disruption  Investor portfolio, but it could be a fun trade.
  It’s clearly going to make millions of dollars selling  ads. You can get your product on the orb for a cool $450,000/day. That works  out to $165 million/year.
Why not put 100 bucks into SPHR and see where it is in  a year?
3. Everybody does it, but no one talks about it.
I’m sure you’ve heard of the “wonder drug” Ozempic. It  suppresses hunger… and helps folks lose weight in a hurry.
  It’s flying off the shelves, and creator Novo  Nordisk’s (NVO) stock is going vertical:
  
  Ozempic has a good chance at being the most successful  product in history. I wouldn’t be surprised if Novo Nordisk sells a trillion  dollars’ worth of it.
  Ozempic is like the new cocaine on Wall Street. Everybody  does it, but no one talks about it.
  Walmart (WMT),  which sells hundreds of billions of dollars’ worth of groceries, says Ozempic  is causing lower food sales.
  Wow! I guarantee no analyst accounted for that in  their price targets.
  But Walmart will be fine… because its pharmacies have  seen a 300% spike in Ozempic sales.
  I’m not a fan of quick-fix pills. I won’t be an  Ozempic customer.
  But when I put my investor glasses on, I see  opportunity.
  Glance up at that chart of Novo Nordisk. You see how  much wealth can quickly be created by making a blockbuster drug?
  These days, 14 of the top 20 best-selling drugs in the  world are biologics—medicines made from living things.
4. Dose of optimism…
One reason I quit corporate finance was because I had  to sit at a desk all day.
  I’m like an energetic kid who sits upside down  watching TV. I like to move, to feel alive.
  That’s why I own a standing desk. I work standing up  to bring the energy… and live longer.
  Recent studies show sitting is the new smoking. People  who sit for eight hours a day with no exercise have a similar risk of dying as  those who puff on cancer sticks!
Stand up. It might just save your life.
Stephen McBride
  Chief Analyst, RiskHedge
To      get more ideas like this sent straight to your inbox every Monday,      Wednesday, and Friday, make sure to sign up for The RiskHedge Report, a      free investment letter focused on profiting from disruption.
  Expect      smart insights and analysis on the latest breakthrough technologies, the      big stories the mainstream media isn't reporting on, and much more...      including actionable recommendations.
Click here      to sign up.
© 2023 Copyright Stephen McBride - All Rights Reserved Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.
© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.
	

  